Cipaglucosidase alfa Alternatives Compared
| Cipaglucosidase alfa | Lumizyme (alglucosidase alfa) | Pombiliti (cipaglucosidase alfa) |
|
|---|
| Cipaglucosidase alfa | Lumizyme (alglucosidase alfa) | Pombiliti (cipaglucosidase alfa) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Pompe Disease. Cipaglucosidase alfa may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pompe Disease. Lumizyme may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pompe Disease. Pombiliti may also be used for purposes not listed in this medication guide. |
Related suggestions Pompe Disease
|
|||||||||||||||
| More about Cipaglucosidase alfa | More about Lumizyme (alglucosidase alfa) | More about Pombiliti (cipaglucosidase alfa) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Cipaglucosidase alfa side effects |
View all Lumizyme side effects |
View all Pombiliti side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Lumizyme prices |
View all Pombiliti prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Pombiliti |
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
2.1 hours |
3.4 hours |
2.1 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
Myozyme
Category C
Risk cannot be ruled out
Lumizyme See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 2 drugs are known to interact with Cipaglucosidase alfa:
|
A total of 1 drugs are known to interact with Lumizyme:
|
A total of 2 drugs are known to interact with Pombiliti:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
September 28, 2023 |
May 24, 2010 |
September 28, 2023 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Myozyme
Myozyme is used to treat a glycogen storage disorder called Pompe disease. Learn about side ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zavesca
Zavesca is used in the treatment of mild to moderate type 1 Gaucher disease. Learn about side ...
Lumizyme
Lumizyme (alglucosidase alfa) is used to treat a glycogen storage disorder called Pompe disease ...
Pombiliti
Pombiliti (cipaglucosidase alfa-agta) is an intravenous infusion that is given over approximately 4 ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.